Profound Medical (TSX:PRN) EPS without NRI: C$-1.63 (TTM As of Mar. 2026)


TSX:PRN Profound Medical Corp TSX:PRN
68 GF Score
Price C$10.46
GF Value C$20.37
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is Profound Medical EPS without NRI?

Profound Medical TSX:PRN +7.28% 68 EPS without NRI is C$-1.63 as of Mar. 2026. GuruFocus rates TSX:PRN with a GF Score™ of 68/100 and a GF Value™ of C$20.37 (Possible Value Trap). The stock has 1 warning sign investors should review. Among 664 Medical Devices & Instruments companies, Profound Medical ranks worse than 60.99% on this metric.

Profound Medical's earnings per share without non-recurring items for the three months ended in Mar. 2026 was C$-0.28. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was C$-1.63.

During the past 3 years, the average earnings per share (NRI) Growth Rate was 0.50% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was -3.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Profound Medical's EPS without NRI or its related term are showing as below:

TSX:PRN' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -6.8   Med: 2.1   Max: 35.5
Current: 0.5

During the past 12 years, Profound Medical's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 35.50% per year. The lowest was -6.80% per year. And the median was 2.10% per year.

TSX:PRN's 3-Year EPS without NRI Growth Rate is ranked worse than
60.99% of 664 companies
in the Medical Devices & Instruments industry
Industry Median: 8.15 vs TSX:PRN: 0.50

Profound Medical's EPS (Diluted) for the three months ended in Mar. 2026 was C$-0.26. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was C$-1.70.

Profound Medical's EPS (Basic) for the three months ended in Mar. 2026 was C$-0.26. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was C$-1.70.


Profound Medical  (TSX:PRN) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Profound Medical EPS without NRI Related Terms


Profound Medical EPS without NRI Historical Data

* Premium members only.

The historical data trend for Profound Medical's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Profound Medical EPS without NRI Chart

Profound Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.92 -1.89 -1.76 -1.82 -1.86

Profound Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.52 -0.63 -0.40 -0.34 -0.28

TSX:PRN vs ABT, SYK, MDT: EPS without NRI Comparison

For the Medical Devices subindustry, Profound Medical's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Profound Medical PE Ratio without NRI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Profound Medical's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Profound Medical's PE Ratio without NRI falls into.


TSX:PRN
68GF Score
Profound Medical Corp TSX:PRN
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Profound Medical EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of C$-1.63 mean?
Profound Medical (TSX:PRN) has a EPS without NRI of C$-1.63 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Profound Medical and its competitors. According to the industry distribution chart, Profound Medical ranks #405 out of 664 companies in the Medical Devices & Instruments industry, placing it in the top 61%.
Is Profound Medical's EPS without NRI too high?
Profound Medical's current EPS without NRI is C$-1.63. Based on the distribution chart, Profound Medical ranks #405 out of 664 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Profound Medical has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Profound Medical's EPS without NRI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Profound Medical ranks #405 out of 664 companies for EPS without NRI. This places Profound Medical in the lower half of its industry. The industry median EPS without NRI is 8.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.15, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Profound Medical and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Profound Medical's current EPS without NRI is C$-1.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Profound Medical stock overvalued right now?
Based on GuruFocus' analysis, Profound Medical (TSX:PRN) is currently considered Possible Value Trap. The stock's GF Value™ is C$20.37, compared to a current price of C$10.46 — trading 48.6% below its estimated fair value. The current EPS without NRI is C$-1.63. Profound Medical's overall GF Score™ is 68/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Profound Medical (TSX:PRN), the current EPS without NRI is C$-1.63 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Profound Medical (TSX:PRN) Overvalued in 2026?

Based on GuruFocus' analysis, Profound Medical stock appears to be undervalued. The current stock price of C$10.46 is trading 48.6% below its estimated GF Value™ of C$20.37. GuruFocus considers Profound Medical to be Possible Value Trap.

Key valuation signals for TSX:PRN:

  • EPS without NRI: C$-1.63
  • GF Value™: C$20.37 vs. price of C$10.46 (48.6% below fair value)
  • GF Score™: 68/100 with 1 warning sign

No single metric tells the full story. See the TSX:PRN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Profound Medical Business Description

Other Exchanges PROF:USA
Address 2400 Skymark Avenue, Unit 6, Mississauga, ON, CAN, L4W 5K5
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
68GF Score

Get the complete analysis for TSX:PRN

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$10.46
Price
C$20.37
GF Value